Zhao Hui Hu

Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu.

Jiangsu Nongken Group Co., Ltd. operates state-owned farms and related assets. The private company is based in Nanjing, China. The Chinese company is a subsidiary ultimately controlled by the Province of Jiangsu. The company was founded in 1952. The CEO is Zhao Hui Hu.